Your browser doesn't support javascript.
loading
Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial.
Croop, Robert; Goadsby, Peter J; Stock, David A; Conway, Charles M; Forshaw, Micaela; Stock, Elyse G; Coric, Vladimir; Lipton, Richard B.
Afiliação
  • Croop R; Biohaven Pharmaceuticals, New Haven, CT, USA. Electronic address: robert.croop@biohavenpharma.com.
  • Goadsby PJ; NIHR-Wellcome Trust King's Clinical Research Facility, King's College Hospital/SLaM Biomedical Research Centre, King's College London, UK; Department of Neurology, University of California, San Francisco, San Francisco, CA, USA.
  • Stock DA; Biohaven Pharmaceuticals, New Haven, CT, USA.
  • Conway CM; Biohaven Pharmaceuticals, New Haven, CT, USA.
  • Forshaw M; Biohaven Pharmaceuticals, New Haven, CT, USA.
  • Stock EG; Biohaven Pharmaceuticals, New Haven, CT, USA.
  • Coric V; Biohaven Pharmaceuticals, New Haven, CT, USA.
  • Lipton RB; Department of Neurology, Albert Einstein College of Medicine, Bronx, NY, USA.
Lancet ; 394(10200): 737-745, 2019 08 31.
Article em En | MEDLINE | ID: mdl-31311674
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Piridinas / Antagonistas do Receptor do Peptídeo Relacionado ao Gene de Calcitonina / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperidinas / Piridinas / Antagonistas do Receptor do Peptídeo Relacionado ao Gene de Calcitonina / Transtornos de Enxaqueca Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2019 Tipo de documento: Article